Henshaw Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,130
Closed -$263K 328
2020
Q2
$263K Sell
2,130
-2,133
-50% -$251K 0.02% 241
2020
Q1
$412K Buy
4,263
+1,001
+31% +$96.6K 0.04% 159
2019
Q4
$302K Hold
3,262
0.02% 200
2019
Q3
$250K Sell
3,262
-316
-9% -$27.6K 0.02% 230
2019
Q2
$308K Sell
3,578
-867
-20% -$59.1K 0.03% 202
2019
Q1
$263K Hold
4,445
0.02% 222
2018
Q4
$234K Buy
+4,445
New +$261K 0.02% 223

Other funds holding RGEN

Henshaw Capital's RGEN Position: Q3 2020 in Review

Henshaw Capital sold out of Repligen (RGEN) in Q3 2020, closing a stake of 2,130 shares — an estimated $263K sold.

Henshaw Capital first reported a position in RGEN in Q4 2018 and held it in 7 quarters. The position peaked at $412K in Q1 2020. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.

  • Henshaw Capital reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
  • Henshaw Capital sold 2,130 Repligen shares in Q3 2020, an estimated $263K.
  • Henshaw Capital first reported a position in Repligen in Q4 2018 and held it in 7 quarters.
  • Henshaw Capital's Repligen position peaked at $412K in Q1 2020.
  • 390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.

Based on Henshaw Capital's 13F filing for Q3 2020, filed 28 May 2026.